Microcap Ledger

Tickers · $SEER

Seer, Inc. $SEER

By Microcap Ledger desk · CIK 0001726445

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Global Select Market
Sector
Laboratory Analytical Instruments
Headquarters
Redwood City, CA
Fiscal year end
December 31
Shares outstanding
55,372,015 [10-Q 2026-08-11]
as of 2026-08-05

Sources: [10-K 2026-03-02]

What the company doesAI summary of filing

Seer, Inc. develops and sells the Proteograph Product Suite, an integrated platform for deep, unbiased proteomic analysis used by researchers in academic institutions, biopharmaceutical companies, biobanks, and clinical research organizations across more than 20 countries. The company generates revenue from the sale of consumable assays, automation instruments, and data analysis software. Since its commercial launch in 2021, Seer has served more than 190 customers and is in the revenue-generating stage, with recent product launches including the Proteograph ONE assay and SP200 automation instrument in May 2025 that enable processing of over 1,000 samples per week. [10-K 2026-03-02]

Segments: Proteograph ONE assay, SP200 automation instrument, Proteograph Analysis Suite (PAS) software, Proteograph DIRECT assay

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$5.89M−$33.74M −$25.01M$26.07M[10-Q 2026-08-11]
FY ended Dec 2025$16.58M−$73.60M −$44.45M$47.28M[10-K 2026-03-02]
FY ended Dec 2024$14.17M−$86.60M −$46.11M$40.75M[10-K 2026-03-02]
Quarterly cash burn
−$12.50M
Cash runway Estimate
~6.3 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2026-02-2356,420,772[10-K/A 2026-04-30]
2026-05-0854,981,551[10-Q 2026-05-13]
2026-08-0555,372,015[10-Q 2026-08-11]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-07-08. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2025-07-088-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-07-08]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-08-18Horn David R.sell7,309$2.03[4 2026-08-19]
2026-07-28Roelofs Nicolas H Phdgrant16,500—[4 2026-07-30]
2026-07-28Ro Isaacgrant12,375—[4 2026-07-30]
2026-07-28Nishar Dipchandgrant16,500—[4 2026-07-30]
2026-07-28Mcguire Terrancegrant16,500—[4 2026-07-30]
2026-07-28Langer Robertgrant16,500—[4 2026-07-30]
2026-07-28Gulyani Meetagrant16,500—[4 2026-07-30]
2026-07-08Nishar Dipchandsell10,660$2.18[4 2026-07-10]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-09-188-KDirector or officer change
2026-08-1110-QQuarterly report
2026-08-118-KResults of operations
2026-07-318-KShareholder vote results
2026-07-318-KOther events
2026-07-208-KOther events
2026-07-028-KOther events
2026-05-228-KOther events
2026-05-1513G/ABeneficial ownership report (5%+ holder)
2026-05-1310-QQuarterly report
2026-05-138-KResults of operations
2026-05-048-KOther events

Facts as of . Small caps move fast; check the latest filings.